In the treatment of PD, catechol-O-methyltransferase (COMT) inhibitors (Kaakkola, 2000) and anticholinergic drugs (Ness et al., 2006) are commonly used even though they may often cause gastrointestinal side effects. The gene discussed is COMT; the disease is Parkinson disease.